August 1992, Volume 42, Issue 8

Editorial

PLEURAL EFFUSION: TRANSUDATE OR EXUDATE

Salimuddin Aziz  ( PMRC Research Centre, Jinnah Postgraduate Medical Centre, Karachi. )

Despite having been studied for 100 years, the physiology of pleural fluid formation and absorption is still controversial1. The most accepted concept is forma­tion by filteration through the pleural microvascular endothelium and absorption via the stomata in the parietal pleura that drains into the subpleurallymphatics. Exudative effusions usually involve inflammation which increases the permeability of pulmonary and pleural vasculature permitting the passage of fluid with high protein content. In transudates the gradient of serum and pleural fluid is maintained because of intact vascular endothelium2. Distinguishing exudates from transudates is the cornerstone in the evolution of pleural effusions because exudative effusions require immediate further workup for early diagnosis as delay in treatment increases both complications and morbidity. Specific gravityand protein levels in pleural fluid were the first parameters to separate transudates from exudates. Laullen and Carr found that 72% of pleural fluids amongst congestive cardiac failure had specific gravity less than 1.0164,5 while 73% had specific gravity more than 1.0 16 but almost 30% were misclassified. Later protein levels were found to be slightly more accurate than specific gravity6 and a protein level of 3.0 grams was taken as the dividing line. In recent years pH measurements of pleural fluid7 (less than or equal to 7.28), pleural fluid/serum protein ratio (less than 0.5) 8, higher serum lectate dehydrogenase levels than pleural fluid (less than or equal to 200 LU) have also been suggested to help in differentiating exudates from transudates9. Light et al. proposed a criteria for diagnosing exudates which included three parameters, i.e., pleural fluid to serum protein ratio of more than 0.5, pleural fluid lectate dehydrogenase levels of more than 200 units per litre and pleural fluid to serum lactate dehydrogenase ratio of above 0.6. This retrospectively designed criterion is said to be 100% sensitive in identifying exudates. Further work identified that pleural fluid to serum bilirubin ratio of 0.6 or more can also serve the same purpose and its sensitivity, specificity, positive predictive accuracy and overall accuracy are above 90% compared to Light\\\'s criteria11. Roth et al. while comparing the serum effusion albumin gradient of 1.2 g/dl or less to diagnose exudates with Light’s criteria found this to be more accurate for transudates. Though Light’s criteria exactly identified all exudates but transudates from five conges­tive cardiac failure patients were misclassified as ex­udates, four of these were treated with diuretics pre­viously. Diuretics are known to increase protein con­centration12,13. Roth’s serum to effusion albumin ratio correctly diagnosed all these five cases but misclassified two malignant effusion cases as transudates. The number evaluated in this study were rather small, but if these findings are confirmed in a large series, it may become a useful investigation for the diagnosis of transudates. Although Light’s criteria is very sensitive for exudates, it should be remembered that diuretic therapy can convert transudates into pscudocxudates14 and, therefore, for the evaluation of pleural fluids, thoracentesis should be performed before the use of diuretic therapy. In fact all collections in body cavities should have a diagnostic tap to differentiate transudates from exudates before any specific therapy is initiated.

REFERENCES

1. Roth, B.J., Omesra, F. and Cragun, N.U. Serum-effusion albumin gradientin evaluation of pleural effusion. Chest, 1990;98:546- 49.
2. Pistolesi. M., Minniata, M. and Giuntini, C. Pleural fluid and solute exchange. Am. Rev. Respir. Dis., 1989; 140:817.
3. Light R.W. Pleural diseases. Philadelphia. Lea and Febiger, 1983. pp. 61-67.
4. Shan, S.A. The pleura. Am.Rev.Respir.Dis., 1988;138: 181-234.
5. Paddok, F.K. Diagnostic significance of serous fluids in disease. N.Engl.J.Med., 1940;223:1010-15.
6. Leuallen, E.G and Carr, D:r. Pleural effusions. A statistical study of 436 patients. N. Engl. J.Med., 1955;252:79-83.
7. Carr, D.T. and Power, M.H. Clinical value of measurements of protein in pleural fluid. N.Engl.J.Med., 1958;259:926-27.
8. Furabashi, A., Sarkar, 3K. and Korey, R.C. Respiratory gas snd pH measurements of pleural fluid. N.Engl.J.Med., 1988: 108:1266.
9. Luetsehers, iA. Eleetrophoretie analysis of proteins and plasma and serous effusions. J. Clin. Invest., 1941;20:90-106.
10. Wroblewski, F. and Wroblewski, R. Clinical significance of lectic dehydrogenase activity of serous effusions. Ann.lntern. Med., 1958;48:813-22.
11. Light, R.W., MacGregor, I., Luehainger. P.C. and Ball, W.C., Jr. Pleural effusions: the diagnostic separation of trsnsudates and exudstes. Ann. Intern. Med., 1972;77:507-13.
12. Meisel, I., Shamiss, A., Michael. T., Nussinovitels, N. and Rosenthal, T. Pleural fluid to serum bilirubin concentration ratio for the separation of transudatea from exudates. Chest, 1990;98:141-44.
13. Gilligsn, D.R., Volk, MC.and Blumgart, H.S. Observations of the chemical and physical relationship between blood serum and body fluids. J. Clin. Invest., 1934; 13:365-81.
14. Pillay, v. Total proteins inserous Iluidsin eardisefailure. S.Afr. Med.J., 1965; 39:142-43
15. Chakko, S.C., Caldwell, SB. and Sforza, PP. Treatment of congestive heart failure: its effect on pleural fluid chemistry. Chest, 1989; 95:798-802.

Journal of the Pakistan Medical Association has agreed to receive and publish manuscripts in accordance with the principles of the following committees: